Journal of Cardiothoracic and Vascular Anesthesia
Volume 20, Issue 4 , Pages 477-483 , August 2006

Myocardial Damage Prevented by Volatile Anesthetics: A Multicenter Randomized Controlled Study

  • Fabio Guarracino, MD

      Affiliations

    • Cardiothoracic Anesthesia and ICU and Cardiac Surgery, Azienda Ospedaliera Universitaria Pisana, Cisanello Hospital, Pisa, Italy
    • ,
  • Giovanni Landoni, MD

      Affiliations

    • Department of Cardiothoracic and Vascular Anesthesia, Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milan, Italy
    • Corresponding Author InformationAddress reprint requests to Giovanni Landoni, MD, Istituto Scientifico San Raffaele, Milano, Italia, via Olgettina 60, Milan 20132, Italy.
    • ,
  • Luigi Tritapepe, MD

      Affiliations

    • Dipartimento di Scienze Anestesiologiche, Medicina Critica e Terapia del Dolore, Università degli Studi “La Sapienza,” Rome, Italy
    • ,
  • Francesca Pompei, MD

      Affiliations

    • Dipartimento di Scienze Anestesiologiche, Medicina Critica e Terapia del Dolore, Università degli Studi “La Sapienza,” Rome, Italy
    • ,
  • Albino Leoni, MD

      Affiliations

    • Department of Cardiothoracic and Vascular Anesthesia, Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milan, Italy
    • ,
  • Giacomo Aletti, PhD

      Affiliations

    • Department of Mathematics, University of Milan, Milan, Italy.
    • ,
  • Anna Mara Scandroglio, MD

      Affiliations

    • Department of Cardiothoracic and Vascular Anesthesia, Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milan, Italy
    • ,
  • Daniele Maselli, MD

      Affiliations

    • Cardiothoracic Anesthesia and ICU and Cardiac Surgery, Azienda Ospedaliera Universitaria Pisana, Cisanello Hospital, Pisa, Italy
    • ,
  • Monica De Luca, MD

      Affiliations

    • Department of Cardiothoracic and Vascular Anesthesia, Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milan, Italy
    • ,
  • Chiara Marchetti, MD

      Affiliations

    • Department of Cardiothoracic and Vascular Anesthesia, Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milan, Italy
    • ,
  • Giuseppe Crescenzi, MD

      Affiliations

    • Department of Cardiothoracic and Vascular Anesthesia, Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milan, Italy
    • ,
  • Alberto Zangrillo, MD

      Affiliations

    • Department of Cardiothoracic and Vascular Anesthesia, Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milan, Italy

References 

  1. Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction . Eur Heart J . 2000;21:1502–1513
  2. Lehrke S , Steen H , Sievers HH , et al.   Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery . Clin Chem . 2004;50:1560–1567
  3. Lasocki S , Provenchere S , Benessiano J , et al.   Cardiac troponin I is an independent predictor of in-hospital death after adult cardiac surgery . Anesthesiology . 2002;97:405–411
  4. Fellahi JL , Gue X , Richomme X , et al.   Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting . Anesthesiology . 2003;99:270–274
  5. Bursi F , Babuin L , Barbieri A , et al.   Vascular surgery patients (perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of postoperative troponin elevation) . Eur Heart J . 2005;26:2448–2456
  6. Kizer JR , Muttrej MR , Matthai WH , et al.   Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention . Eur Heart J . 2003;24:1314–1322
  7. Selvanayagam JB , Porto I , Channon K , et al.   Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury (Insights from cardiovascular magnetic resonance imaging) . Circulation . 2005;111:1027–1032
  8. Horwich TB , Patel J , MacLellan WR , et al.   Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure . Circulation . 2003;108:833–838
  9. Selvanayagam JB , Pigott D , Balacumaraswami L , et al.   Relationship of irreversible myocardial injury to troponin I and creatine kinase-MB elevation after coronary artery bypass surgery (insights from cardiovascular magnetic resonance imaging) . J Am Coll Cardiol . 2005;45:629–631
  10. American Heart Association . Heart Disease and Stroke Statistics—2003 Update . Dallas, TX: American Heart Association; 2003; p 46
  11. De Hert SG . The concept of anaesthetic-induced cardioprotection (Clinical relevance) . Best Pract Res Clin Anaesthesiol . 2005;19:445–459
  12. De Hert SG , Turani F , Mathur S , et al.   Cardioprotection with volatile anesthetics (Mechanisms and clinical implications) . Anesth Analg . 2005;100:1584–1593
  13. Weber NC , Schlack W . The concept of anaesthetic-induced cardioprotection (Mechanisms of action) . Best Pract Res Clin Anaesthesiol . 2005;19:429–443
  14. Zaugg M , Schaub MC , Foex P . Myocardial injury and its prevention in the perioperative setting . Br J Anaesth . 2004;93:21–33
  15. Kato R , Foex P . Myocardial protection by anaesthetic agents against ischemia-reperfusion injury (An update for anesthesiologists) . Can J Anaesth . 2002;49:777–791
  16. Riess ML , Stowe DF , Warltier DC . Cardiac pharmacological preconditioning with volatile anesthetics (From bench to bedside?) . Am J Physiol Heart Circ Physiol . 2004;286:H1603–H1607
  17. Piriou V , Chiari P . Con (Ischemic preconditioning is not necessary because volatile agents accomplish it) . J Cardiothorac Vasc Anesth . 2004;18:803–805
  18. Cohen G , Shirai T , Weisel RD , et al.   Optimal myocardial preconditioning in a human model of ischemia and reperfusion . Circulation . 1998;98:II184–II196
  19. De Hert SG , Van der Linden PJ , et al.   Choice of primary anaesthetic regimen can influence intensive care unit length of stay in coronary surgery with cardiopulmonary bypass . Anesthesiology . 2004;101:9–20
  20. De Hert SG , Van der Linden PJ , Cromheecke S , et al.   Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration . Anesthesiology . 2004;101:299–310
  21. Belhomme D , Peynet J , Louzy M , et al.   Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery . Circulation . 1999;100:II340–II344
  22. Tomai F , De Paulis R , Penta de Peppo A , et al.   Beneficial impact of isoflurane during coronary bypass surgery on troponin I release . G Ital Cardiol . 1999;29:1007–1014
  23. De Hert SG , ten Broecke PW , Mertens E , et al.   Sevoflurane but not propofol preserves myocardial function in coronary surgery patients . Anesthesiology . 2002;97:42–49
  24. Conzen PF , Fischer S , Detter C , et al.   Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery . Anesthesiology . 2003;99:826–833
  25. Bein B , Renner J , Caliebe D , et al.   Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery . Anesth Analg . 2005;100:610–616
  26. Murphy GJ , Ascione R , Angelini GD . Coronary artery bypass grafting on the beating heart (Surgical revascularization for the next decade?) . Eur Heart J . 2004;25:2077–2085
  27. Cheng DC , Bainbridge D , Martin JE , et al.  Evidence-Based Perioperative Clinical Outcomes Research Group   Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials . Anesthesiology . 2005;102:188–203
  28. Toller WG , Gross ER , Kersten JR , et al.   Sarcolemmal and mitochondrial adenosine triphosphate–dependent potassium channels (Mechanism of desflurane-induced cardioprotection) . Anesthesiology . 2000;92:1731–1739
  29. Crescenzi G , Cedrati V , Landoni G , et al.   Cardiac biomarker release after CABG with different surgical techniques . J Cardiothorac Vasc Anesth . 2004;18:34–37
  30. Altman DG, Machin D, Bryant TN, et al: Statistics with Confidence. Available at: http://www.bmjbooks.com. Accessed
  31. Murry CE , Jennings RB , Reimer KA . Preconditioning with ischemia (a delay of lethal cell injury in ischemic myocardium) . Circulation . 1986;74:1124–1136
  32. Julier K , da Silva R , Garcia C , et al.   Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery (A double-blinded, placebo-controlled, multicenter study) . Anesthesiology . 2003;98:1315–1327
  33. Garcia C , Julier K , Bestmann L , et al.   Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery . Br J Anaesth . 2005;94:159–165
  34. Eagle KA , Berger PB , Calkins H , et al.   ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—Executive summary (A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)) . Circulation . 2002;105:1257–1267

 Desflurane (Suprane) was provided free of charge by the producer (Baxter).

PII: S1053-0770(06)00231-X

doi: 10.1053/j.jvca.2006.05.012

Journal of Cardiothoracic and Vascular Anesthesia
Volume 20, Issue 4 , Pages 477-483 , August 2006

Article Tools

* Image Usage & Resolution